Hello Avatar! Welcome to another week of biotech analysis. Not much has changed in a week, broader markets and biotech are still down, burdened by war and economic uncertainty. Last week we laid out a positive scenario for how this market can turn itself around. This week we continue on that theme examining potential unexpected catalysts on both the …
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.